83 related articles for article (PubMed ID: 1849940)
1. Transforming growth factor-beta (TGF-beta)-resistant helper T lymphocyte clones show a concomitant loss of all three types of TGF-beta receptors.
Siepl C; Malipiero UV; Fontana A
J Immunol; 1991 May; 146(9):3063-7. PubMed ID: 1849940
[TBL] [Abstract][Full Text] [Related]
2. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
Kumar A; Rogers T; Maizel A; Sharma S
J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
[TBL] [Abstract][Full Text] [Related]
3. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta 1 in liver carcinogenesis: messenger RNA expression and growth effects.
Braun L; Gruppuso P; Mikumo R; Fausto N
Cell Growth Differ; 1990 Mar; 1(3):103-11. PubMed ID: 1964076
[TBL] [Abstract][Full Text] [Related]
5. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling.
Ito M; Yasui W; Kyo E; Yokozaki H; Nakayama H; Ito H; Tahara E
Cancer Res; 1992 Jan; 52(2):295-300. PubMed ID: 1309437
[TBL] [Abstract][Full Text] [Related]
7. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1.
Braun L; Dürst M; Mikumo R; Gruppuso P
Cancer Res; 1990 Nov; 50(22):7324-32. PubMed ID: 2171761
[TBL] [Abstract][Full Text] [Related]
8. The glioblastoma-derived T cell suppressor factor/transforming growth factor-beta 2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor.
Siepl C; Bodmer S; Frei K; MacDonald HR; De Martin R; Hofer E; Fontana A
Eur J Immunol; 1988 Apr; 18(4):593-600. PubMed ID: 2452745
[TBL] [Abstract][Full Text] [Related]
9. Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation.
Taipale J; Matikainen S; Hurme M; Keski-Oja J
Cell Growth Differ; 1994 Dec; 5(12):1309-19. PubMed ID: 7696179
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression.
Weller M; Constam DB; Malipiero U; Fontana A
Eur J Immunol; 1994 Jun; 24(6):1293-300. PubMed ID: 8206089
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL
Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors.
Zhou GH; Sechrist GL; Periyasamy S; Brattain MG; Mulder KM
Cancer Res; 1995 May; 55(10):2056-62. PubMed ID: 7743502
[TBL] [Abstract][Full Text] [Related]
13. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
[TBL] [Abstract][Full Text] [Related]
14. Altered responsiveness of rat liver epithelial cells to transforming growth factor beta 1 following their transformation with v-raf.
Huggett AC; Hampton LL; Ford CP; Wirth PJ; Thorgeirsson SS
Cancer Res; 1990 Dec; 50(23):7468-75. PubMed ID: 2174726
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor beta-1 (TGF-beta 1) and alters the number and type of TGF-beta 1 receptors in rat intestinal epithelial cell clones.
Filmus J; Zhao J; Buick RN
Oncogene; 1992 Mar; 7(3):521-6. PubMed ID: 1312703
[TBL] [Abstract][Full Text] [Related]
16. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
Kezuka T; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
[TBL] [Abstract][Full Text] [Related]
17. Suppression of serum IgE response and systemic anaphylaxis in a food allergy model by orally administered high-dose TGF-beta.
Okamoto A; Kawamura T; Kanbe K; Kanamaru Y; Ogawa H; Okumura K; Nakao A
Int Immunol; 2005 Jun; 17(6):705-12. PubMed ID: 15837712
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin.
Dumont FJ; Kastner CA
J Cell Physiol; 1994 Jul; 160(1):141-53. PubMed ID: 8021294
[TBL] [Abstract][Full Text] [Related]
19. Cognate interactions between helper T cells and B cells. VI. TGF-beta inhibits B cell activation and antigen-specific, physical interactions between Th and B cells.
Bartlett WC; Purchio A; Fell HP; Noelle RJ
Lymphokine Cytokine Res; 1991 Jun; 10(3):177-83. PubMed ID: 1832051
[TBL] [Abstract][Full Text] [Related]
20. Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells.
Franzén P; Ichijo H; Miyazono K
Exp Cell Res; 1993 Jul; 207(1):1-7. PubMed ID: 7686495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]